Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy and Reduced Dose RT for HPV+ Oropharyngeal Cancer
NCT01525927Phase 2Terminated
- Sponsor
- Northwell Health
- Start
- Aug 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin, fluorouracil in oropharyngeal squamous cell carcinoma (OPSCC), sponsored by Northwell Health. Started Aug 2010; status: terminated.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on NCT01525927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525927.